ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,734 | -19.8% | 4,578 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $17,122 | -27.8% | 4,578 | -7.1% | 0.00% | 0.0% |
| Q4 2022 | $23,704 | -15.5% | 4,928 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,040 | -19.9% | 4,928 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $34,989 | -1.7% | 4,928 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $35,580 | -78.9% | 4,928 | -73.9% | 0.00% | -50.0% |
| Q4 2021 | $168,707 | -74.5% | 18,871 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $661,617 | +131.9% | 18,871 | +308.4% | 0.01% | +150.0% |
| Q1 2021 | $285,347 | +40.9% | 4,621 | -4.7% | 0.00% | +33.3% |
| Q4 2020 | $202,508 | – | 4,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |